Experimental Trial of rhIFNα Nasal Drops to Prevent 2019-nCOV in Medical Staff

NCT04320238 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

2944

Enrollment

OTHER

Sponsor class

Conditions

2019 Novel Coronavirus Infection

Interventions

DRUG: recombinant human interferon Alpha-1b
DRUG: thymosin alpha 1

Sponsor

Shanghai Jiao Tong University School of Medicine